StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.38−0.47 (-25.41%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

Cel Sci gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Cel Sci

Cel Sci has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cel Sci figures

See a number that looks wrong?